IL6 and prediabetes syndrome: Given that prediabetes is marked by low-grade inflammation and early endothelial dysfunction, IL-6 may serve as a marker for detection through sensitive biomarker monitoring in this group, offering a window of opportunity for early intervention before overt macrovascular damage occurs.